Safety and efficacy of idarucizumab-assisted thrombolysis in dabigatran-related acute ischemic stroke: a systematic review and single-arm meta-analysis. [PDF]
Front NeurolGuo X +6 more
europepmc +1 more source
Intravenous thrombolysis in acute ischemic stroke after recent direct oral anticoagulant intake: toward evidence-informed care. [PDF]
Front NeurolZupan M, Šabovič M, Kermer P, Frol S.
europepmc +1 more source
Disseminated Intravascular Coagulation Following Idarucizumab and Andexanet Alfa: Assessment of a Signal of Disproportionate Reporting From the Food and Drugs Administration Adverse Event Reporting System (FAERS) Database. [PDF]
Drug SafRoberto G +7 more
europepmc +1 more source
Current Status of the Safety and Efficacy of Antidotes for Direct Oral Anticoagulants in Japan. [PDF]
JACC AsiaKodani E.
europepmc +1 more source
From empirical hemostasis to precision reversal: clinical challenges, technological innovations, and individualized strategies in anticoagulant-associated bleeding. [PDF]
Front Cardiovasc MedZheng W +6 more
europepmc +1 more source
Overcoming inertia in anticoagulant reversal: the current evidence gap and need for critical assessment of factor replacement strategies. [PDF]
Front Cardiovasc MedMahan CE +14 more
europepmc +1 more source
Perioperative management of direct oral anticoagulant-treated patients who need urgent surgery. [PDF]
Res Pract Thromb HaemostCarlin S, Godoy A, Douketis J.
europepmc +1 more source
Management of bleeding and nonelective invasive procedures in patients receiving direct oral anticoagulants (DOACs): a 5-year single-center observational study. [PDF]
Res Pract Thromb HaemostPontis A +9 more
europepmc +1 more source
Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds [PDF]
Circulation, 2019 Deborah M, Siegal, Stuart J, Connolly
openaire +2 more sources
Anticoagulation Stewardship Program in the DOAC Era. [PDF]
J Clin MedNg JX, Tan SC, Koh PL, Yap ES.
europepmc +1 more source